Atlas Trials

Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma

Clinical trial NCT05256459 · UNKNOWN

Trial details

NCT number
NCT05256459
Sponsor
Zhang Dazhi,MD
Status
UNKNOWN
Study type
OBSERVATIONAL
Time
Start date
2022-05-10
Primary completion
2024-12-15
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.